AsOf

Recorded or changed on this day 2026-11-08

401–450 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 725,000,000 United States dollar
Abbott Laboratories quarterly research and development: 725,000,000 United States dollar, claim clm_B9E52815E3A9 · ended · superseded by clm_1266BBB313EF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,734,455,213 shares
Abbott Laboratories shares outstanding: 1,734,455,213 shares, claim clm_B9E574E3CE32 · ended · superseded by clm_C9A2257584AB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 8,937,000,000 United States dollar
Abbott Laboratories cash and equivalents: 8,937,000,000 United States dollar, claim clm_B9EFB00ADC3F · ended · superseded by clm_521772051B63 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 564,000,000 United States dollar
Abbott Laboratories quarterly research and development: 564,000,000 United States dollar, claim clm_BB551BCBB517 · ended · superseded by clm_5227340047B9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,735,184,289 shares
Abbott Laboratories shares outstanding: 1,735,184,289 shares, claim clm_BBA1010F4237 · ended · superseded by clm_97F2C8360ADC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 21,335,055,000 United States dollar
Abbott Laboratories total equity: 21,335,055,000 United States dollar, claim clm_BBD426555711 · ended · superseded by clm_B8C5187C21F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,377,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,377,000,000 United States dollar, claim clm_BC21405CF5E5 · ended · superseded by clm_12D7EF8B99CE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 8,826,014,000 United States dollar
Abbott Laboratories quarterly revenue: 8,826,014,000 United States dollar, claim clm_BC7C9A4BD8E1 · ended · superseded by clm_A55F00358DA8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 37,010,000,000 United States dollar
Abbott Laboratories total equity: 37,010,000,000 United States dollar, claim clm_BCA71643FBC3 · ended · superseded by clm_2FAA1610921D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 74,356,000,000 United States dollar
Abbott Laboratories total assets: 74,356,000,000 United States dollar, claim clm_BCEDE84B5D8A · ended · superseded by clm_114AF086ADE9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,747,000,000 United States dollar
Abbott Laboratories quarterly revenue: 9,747,000,000 United States dollar, claim clm_BDD05EB44D8B · ended · superseded by clm_6B2DDDB45AF4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,979,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,979,000,000 United States dollar, claim clm_BDDE4A079F3F · ended · superseded by clm_6EA4DA762D97 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,616,000,000 United States dollar
Abbott Laboratories cash and equivalents: 7,616,000,000 United States dollar, claim clm_BE323442D575 · ended · superseded by clm_7C1DF4950D60 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 42,953,000,000 United States dollar
Abbott Laboratories total assets: 42,953,000,000 United States dollar, claim clm_BE81EC5EFEDD · ended · superseded by clm_5B183F58E77F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,284,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,284,000,000 United States dollar, claim clm_BE85A98DAC5B · ended · superseded by clm_16E584C7B895 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,060,759,000 United States dollar
Abbott Laboratories quarterly operating income: 1,060,759,000 United States dollar, claim clm_BF0249D28592 · ended · superseded by clm_998AAAD07809 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 30,764,707,000 United States dollar
Abbott Laboratories revenue: 30,764,707,000 United States dollar, claim clm_BF21BA903CA4 · ended · superseded by clm_FBAB25A659DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 44,125,000,000 United States dollar
Abbott Laboratories total assets: 44,125,000,000 United States dollar, claim clm_BFEBD87BE412 · ended · superseded by clm_5EAB483532A7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,535,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,535,000,000 United States dollar, claim clm_C0322CACEF5F · ended · superseded by clm_BDDE4A079F3F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 784,000,000 United States dollar
Abbott Laboratories quarterly net income: 784,000,000 United States dollar, claim clm_C09A927BCCDA · ended · superseded by clm_94B13D450A74 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,373,120,000 United States dollar
Abbott Laboratories cash and equivalents: 4,373,120,000 United States dollar, claim clm_C0BA9C433C47 · ended · superseded by clm_3B7BA4C79E00 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 8,522,000,000 United States dollar
Abbott Laboratories cash and equivalents: 8,522,000,000 United States dollar, claim clm_C0C2E64C6F88 · ended · superseded by clm_F4A9C9EE7593 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,390,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,390,000,000 United States dollar, claim clm_C3C0F612B29F · ended · superseded by clm_79374FAAB118 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 2,576,000,000 United States dollar
Abbott Laboratories net income: 2,576,000,000 United States dollar, claim clm_C538B005C944 · ended · superseded by clm_B11F523F3F14 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 614,788,000 United States dollar
Abbott Laboratories quarterly operating income: 614,788,000 United States dollar, claim clm_C62521896403 · ended · superseded by clm_A62E02723D32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 34,608,000,000 United States dollar
Abbott Laboratories revenue: 34,608,000,000 United States dollar, claim clm_C6D9CE4452DC · ended · superseded by clm_DA5BB69D989B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 23,390,000,000 United States dollar
Abbott Laboratories total equity: 23,390,000,000 United States dollar, claim clm_C84177F7FADC · ended · superseded by clm_820EF0E3F09E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 577,000,000 United States dollar
Abbott Laboratories quarterly research and development: 577,000,000 United States dollar, claim clm_C910D6802F6E · ended · superseded by clm_D72480210DBD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 38,810,000,000 United States dollar
Abbott Laboratories total equity: 38,810,000,000 United States dollar, claim clm_C93071E72423 · ended · superseded by clm_963EBDDEF424 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,734,323,411 shares
Abbott Laboratories shares outstanding: 1,734,323,411 shares, claim clm_C9A2257584AB · ended · superseded by clm_D943BAA75A0F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,750,942,289 shares
Abbott Laboratories shares outstanding: 1,750,942,289 shares, claim clm_CA76322E4A79 · ended · superseded by clm_DFFA512578F3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,844,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,844,000,000 United States dollar, claim clm_CAD5272C9D86 · ended · superseded by clm_166B1C725C2A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 27,014,175,000 United States dollar
Abbott Laboratories total equity: 27,014,175,000 United States dollar, claim clm_CAE9CB28DB1F · ended · superseded by clm_24230E6F3612 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,321,702,000 United States dollar
Abbott Laboratories cash and equivalents: 4,321,702,000 United States dollar, claim clm_CBC630AE4E8D · ended · superseded by clm_3550C577271B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 27,390,000,000 United States dollar
Abbott Laboratories revenue: 27,390,000,000 United States dollar, claim clm_CBCFC23B00BC · ended · superseded by clm_B704D1D4A319 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,420,000,000 United States dollar
Abbott Laboratories research and development: 2,420,000,000 United States dollar, claim clm_CCB485006F63 · ended · superseded by clm_F186D437CBF8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 53,381,402,000 United States dollar
Abbott Laboratories total assets: 53,381,402,000 United States dollar, claim clm_CCF6757E8FC3 · ended · superseded by clm_0A2F6FD9A825 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,524,000,000 United States dollar
Abbott Laboratories total equity: 30,524,000,000 United States dollar, claim clm_CD188CE803B5 · ended · superseded by clm_7D62673F73F6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,874,795,000 United States dollar
Abbott Laboratories cash and equivalents: 4,874,795,000 United States dollar, claim clm_CD7C420909AE · ended · superseded by clm_7367F0AB540E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,503,699,033 shares
Abbott Laboratories shares outstanding: 1,503,699,033 shares, claim clm_CDA367FBFDF8 · ended · superseded by clm_046691A1A0C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 71,151,000,000 United States dollar
Abbott Laboratories total assets: 71,151,000,000 United States dollar, claim clm_CDC7CB62542B · ended · superseded by clm_129A9E1E6676 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 39,796,000,000 United States dollar
Abbott Laboratories total equity: 39,796,000,000 United States dollar, claim clm_CE6B68D9DE0E · ended · superseded by clm_117E87574745 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 22,588,186,000 United States dollar
Abbott Laboratories total equity: 22,588,186,000 United States dollar, claim clm_CEDF1D0510CD · ended · superseded by clm_FA0A4E638F4A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,006,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,006,000,000 United States dollar, claim clm_CEF1F2D39061 · ended · superseded by clm_E5DF870B61C4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 42,514,000,000 United States dollar
Abbott Laboratories total assets: 42,514,000,000 United States dollar, claim clm_CF1CC29BF075 · ended · superseded by clm_2B6AC140F47C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 13,402,000,000 United States dollar
Abbott Laboratories net income: 13,402,000,000 United States dollar, claim clm_CF3E98D0B268 · ended · superseded by clm_76AC317902A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 23,696,237,000 United States dollar
Abbott Laboratories total equity: 23,696,237,000 United States dollar, claim clm_CFE8748CEC34 · ended · superseded by clm_25A96CED8FE3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 589,000,000 United States dollar
Abbott Laboratories quarterly research and development: 589,000,000 United States dollar, claim clm_D0387CB879C0 · ended · superseded by clm_6B0B3077A414 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,613,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,613,000,000 United States dollar, claim clm_D03CCE99B6F0 · ended · superseded by clm_29AA3D4C2CD2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 684,000,000 United States dollar
Abbott Laboratories quarterly research and development: 684,000,000 United States dollar, claim clm_D0D6418B59F7 · ended · superseded by clm_6768B441C8E0 · 1 source (1 primary) · conf 0.95

What the statuses mean